Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-07 · accession 0000950170-24-124232 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-11-08 | 2024-11-07 | MDGL | Levy Richard S | Dir | M - OptEx | $7.36 | +5,000 | 16.0K | +45% | +$36.8K |
| DT | 2024-11-08 | 2024-11-07 | MDGL | Levy Richard S | Dir | S - Sale+OE | $350.00 | -5,000 | 11.0K | -31% | -$1.75M |
| DT | 2024-11-08 | 2024-11-07 | MDGL | Levy Richard S | Dir | M - OptEx | $0.00 | -5,000 | 5,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | M | A | 5,000 | $7.36 | 16,012 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-07 | S | D | 5,000 | $350.00 | 11,012 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-11-07 | M | D | 5,000 | $0.00 | 5,000 | D | $7.36 · — to 2026-08-11 | 5,000 Common Stock | (F2) The shares underlying this option are fully vested and exercisable. |